Related Experiment Video
Updated: Sep 4, 2025
06:29
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
30.7K
[Thrombotic risk in autoimmune hemolytic anemia]
1Department of Hematology and Oncology, Osaka University Graduate School of Medicine.
Summary
Autoimmune hemolytic anemia (AIHA) involves red blood cell destruction by autoantibodies. Treatments should address both anemia and the increased risk of thrombosis in AIHA patients.
Area of Science:
- Hematology
- Immunology
Background:
- Autoimmune hemolytic anemia (AIHA) is characterized by autoantibody-mediated red blood cell destruction.
- AIHA presents as warm or cold types, with symptoms including anemia, jaundice, and circulatory issues.
- Both AIHA types elevate thrombosis risk, with intravascular hemolysis being a key pathogenic factor.
Purpose of the Study:
- To review the pathogenesis of autoimmune hemolytic anemia.
- To highlight the role of complement activation in intravascular hemolysis.
- To emphasize the contribution of coagulation and hemostasis to AIHA-associated thrombosis.
Main Methods:
- Literature review of AIHA pathogenesis.
- Analysis of the interplay between hemolysis, complement, and coagulation systems.
Main Results:
- Intravascular hemolysis is critical in AIHA pathogenesis.
- Complement activation drives hemolysis.
- Coagulation and hemostatic systems significantly contribute to thrombosis in AIHA.
Conclusions:
- AIHA pathogenesis involves complex interactions between immune and hemostatic systems.
- Reducing thrombotic risk is crucial for effective AIHA management.
- Future therapies should target both anemia and thrombosis prevention.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
872
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
872
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
02:45Blood Transfusion and Agglutination
11.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.1K
01:30Venous Thrombosis I: Introduction
37
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
37
01:19Rh Blood Group
1.8K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.8K
01:29Venous Thrombosis III: Interprofessional Care
20
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
20